Standard Glass IPO: Price Band Set at ₹133-140, Opens January 6

Standard Glass Lining Technology Ltd, one of the upcoming IPOs, has announced a price band of ₹133-140 per share for its upcoming ₹410.05 crore Initial Public Offering (IPO). The IPO, the first mainboard offering of 2025, will open for public subscription on January 6 and close on January 8. Anchor investors can start bidding from January 3.

The minimum bid size is set at 107 shares, and investors can bid in multiples thereafter.

Issue Structure

The IPO includes:

• Fresh Issue: Equity shares worth ₹210 crore.
• Offer for Sale (OFS): Up to 1.43 crore shares, reduced from the earlier planned 1.84 crore shares.

Selling shareholders in the OFS include S2 Engineering Services, Standard Holdings, and individual promoters like Kandula Ramakrishna and Katragadda Venkata Ramani, among others.

Utilisation of Proceeds

The funds raised through the fresh issue will be utilised for:

• ₹130 crore: Repayment of debt.
• ₹30 crore: Investment in wholly-owned subsidiary S2 Engineering Industry.
• ₹20 crore: Strategic investments or acquisitions for inorganic growth.
• ₹10 crore: Purchase of machinery and equipment.
• Remaining funds: General corporate purposes.

About the Company

Based in Telangana, Standard Glass provides end-to-end solutions for pharmaceutical and chemical manufacturers, including design, engineering, manufacturing, assembly, installation, and commissioning. It also manages the entire production process in-house.

Key Clients

Prominent pharmaceutical clients include Aurobindo Pharma, Cadila Pharmaceutical, Granules India, Macleods Pharmaceuticals, Piramal Pharma, and Suven Pharmaceuticals.

Listing and Management

The shares will be listed on both stock exchanges, Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). IIFL Capital Services Ltd and Motilal Oswal Investment Advisors Ltd are the book-running lead managers, while KFin Technologies is the registrar.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.